Long-Term Follow-Up of Patients With Tuberculosis as a Complication of Tumour Necrosis Factor (TNF)-α Antagonist Therapy: Safe Re-Initiation of TNF-α Blockers After Appropriate Anti-Tuberculous Treatment

Clinical Microbiology and Infection - United Kingdom
doi 10.1111/j.1469-0691.2007.01891.x